The LTC Innovation Blog

In July during a virtual coffee chat with one of my pharmacy clients, we explored COVID-19 and its tremendous impact on stress levels within the nursing staff.

There's no denying the complexities that come with managing the ins and outs of any long-term care pharmacy: everything from remaining compliant with federal, state, and local regulations to making sure that pharmaceutical supply chains run smoothly. But every modern avenue of business has its difficulties. The onus of addressing them, of course, falls squarely on the shoulders of pharmacy leaders.

On October 24, 2018, the SUPPORT Act was signed into law, marking the single largest bill to combat the drug crisis in the history of the United States. This law combined 42 separate pieces of legislation, all aimed at making treatment for opioid addiction more available, while at the same time reducing the illicit use of controlled substances.

As more and more states address controlled substance abuse and the opioid crisis, Long-Term Care (LTC) pharmacies are feeling the urgency and need to be compliant with ever-increasing regulatory requirements. PDMP (Prescription Drug Monitoring Program) reporting guidelines vary by state, and regulations are often changing.

“How could my pharmacy better support our SNF clients right now?”